Blockchain Registration Transaction Record
Gemina Labs Set to Transform Rapid Testing with Next-Gen Technology
Gemina Laboratories, led by CEO Brian Firth, is set to revolutionize the rapid testing industry with breakthrough technology, impacting the global in vitro diagnostics market and potentially saving billions in costs.
Gemina Laboratories' innovative technology has the potential to revolutionize the rapid diagnostics industry, making affordable, lab-accurate diagnostics available worldwide. The company's breakthroughs not only save costs but also improve the accuracy and usability of diagnostic tests, ultimately reducing the spread of life-threatening illnesses and saving billions in the diagnostics sector. This news is important for investors and industry stakeholders, as Gemina Labs is positioning itself as a transformative force with the potential to revolutionize how rapid diagnostics are developed and deployed globally.
Blockchain | Details |
---|---|
Contract Address | 0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71 |
Transaction ID | 0x055abe5f4ea23cf063742dac62f0df57ea4d8a3b767da85c7a09ac6a1fd11b70 |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | riceW5ld-35d380cd22d9f6d5ca33b699eebe5096 |